SelectScience
Join Free
Accelerating Science
NewsLife Sciences

SeraCare Life Sciences Sets Up Advisory Board to Spark Advancements in Oncology Diagnostics

SeraCare Life Sciences
12 Feb 2014
Sonia Nicholas
Managing Editor and Clinical Lead

Industry news

Dr. Jack Wands Joins SeraCare Science Advisory Board

SeraCare Life Sciences, a provider of high quality biological materials and reagents that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today introduced Dr. Jack Wands as the founding member of the SeraCare Science Advisory Board. This group will bring together thought leaders in emerging technologies and applications such as NexGen sequencing, clinical oncology and autoimmune disease to foster collaboration and innovation.

“We are excited to welcome Dr. Wands as the first member of the SeraCare Science Advisory Board,” said Russell Garlick, Ph.D., Chief Scientific Officer at SeraCare. “Dr. Wands is an internationally renowned physician scientist and we share a vision for harnessing the power of precision medicine to advance oncology diagnostics. Each day brings new innovation in our industry, making it more important than ever that we join forces with the leading research minds.”

“SeraCare plays a critical role in the discovery of new diagnostic tools and their transformation into commercial products that improve patients’ lives,” said Dr. Jack Wands, Professor of Medical Science at Brown Medical School. “It is deeply rewarding to me to join the Science Advisory Board so I can not only share insights with other researchers, but also see these concepts brought to life in a way that positively impacts so many people.”

Dr. Wands is the Jeffrey and Kimberly Greenberg-Artemis and Martha Joukowsky Professor in Gastroenterology, and Professor of Medical Science, Brown Medical School. He founded and developed the Rhode Island Hospital/Brown University Liver Research Center. His research efforts involve the role of hepatitis B and C infection in the pathogenesis of hepatocellular carcinoma at the molecular level. Dr. Wands received his M.D. with High Honors from the University Of Washington School Of Medicine, was Chief Resident in Medicine at JohnsHopkins Bayview Medical Center and was a Clinical and Research Fellow at Massachusetts General Hospital.


Image Caption: Dr Jack Wands

Links

SeraCare Life SciencesCompany website

Tags

Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Cellular PathologyCellular Pathology deals with the microscopic analysis of tissue samples and cells. Sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats. In choosing immunohistochemistry and immunocytochemistry kits, consider chromogens, staining method, antibodies, microscopes and imaging.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Next Generation SequencingNext-generation sequencing (NGS), also known as whole-genome sequencing, high-throughput sequencing and massive parallel sequencing, produces and analyses thousands to millions of nucleotide sequences at once. Sequencing systems operate via varying technologies depending on the manufacturer, including sequencing by synthesis, ligation, pyrosequencing, ion semiconductor and single-molecule real-time sequencing. For NGS, library preparation is paramount to successful sequencing. In this section, explore a range of library preparation kits, from targeted, amplicon-based or hybridization-based kits including epigenomic, transcriptomic and genomic workflows to fragmentation kits. Find the best next-generation sequencing products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Cancer DiagnosticsThere are a wide variety of diagnostic tests for cancer available, and this range continues to expand as our knowledge of cancer improves. Current diagnostic methods include biopsy, imaging and blood tests for known biomarkers. New methods in research development include liquid biopsies and cancer breathalyzers.

Related articles

SeraCare Life Sciences Sets Up Advisory Board to Spark Advancements in Oncology Diagnostics